| 2025-10-01 | Class II | Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Onl | Aspiro Pharma Limited |
| 2025-09-05 | Class II | Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmo | Apotex Corp. |
| 2025-05-28 | Class II | Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 10 mL, Rx Only, Manufactured by: Apotex Inc., Toronto, Ontar | Apotex Corp. |
| 2022-08-10 | Class II | Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose vials, Rx Only, Neph | Nephron Sc Inc |
| 2020-12-23 | Class I | Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 | Fresenius Kabi USA, LLC |
| 2020-12-17 | Class II | Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, Rx on | Fresenius Kabi USA, LLC |
| 2020-04-20 | Class II | Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vials (NDC | Fresenius Kabi USA, LLC |
| 2020-04-20 | Class I | Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 | Fresenius Kabi USA, LLC |
| 2019-12-17 | Class I | Ketorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL Single Dose Vials (NDC 0641-6042-01), 25 vial | Hikma Pharmaceuticals USA Inc. |
| 2019-12-17 | Class II | Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose Vials (NDC 0641-6043 | Hikma Pharmaceuticals USA Inc. |
| 2019-04-30 | Class II | Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), 2 mL Vials, Rx only, Mfd. for Sagent Ph | Sagent Pharmaceuticals Inc |
| 2015-06-30 | Class II | KETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose Vials, I.V/I.M. USE, Hospira, Inc., | Hospira Inc. |
| 2015-06-30 | Class II | KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., | Hospira Inc. |
| 2015-01-23 | Class II | KETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose Vials, I.V/I.M. USE, Hospira, Inc., | Hospira Inc. |
| 2015-01-23 | Class II | KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., | Hospira Inc. |
| 2014-10-06 | Class II | Ketorolac Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Single-dose Fliptop Vial, packaged in 25 Units per ca | Hospira Inc. |
| 2014-10-03 | Class II | Ketorolac Tromethamine INJECTION, USP, 30 mg per mL, a) 1 mL vial (NDC 25021-701-01) b) 2 mL vial (NDC 25021-7 | Sagent Pharmaceuticals Inc |
| 2013-08-12 | Class II | Ketorolac Tromethamine Inj., USP, 30 mg vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-379 | Hospira, Inc. |